Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs

Osteoarthritis and Cartilage

Volumn 20, Issue 5, 2012, Pages 339-349

  Barter, M J ^a   Bui, C ^a   Young, D A ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Cartilage; Chromatin; DNA methylation; Epigenetics; MicroRNAs

Indexed keywords

AGGRECANASE 1; COLLAGENASE 3; DICER; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 5; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE INHIBITOR; MICRORNA; MICRORNA 140; PROTEIN ARGININE METHYLTRANSFERASE; RESVERATROL; SIRTUIN 1; SOMATOMEDIN; STROMELYSIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANTERIOR CRUCIATE LIGAMENT; CARTILAGE; CARTILAGE CELL; CELL DIVISION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; DNA REPLICATION; ENZYME INDUCTION; EPIGENETICS; EXCISION REPAIR; EXTRACELLULAR MATRIX; GENE EXPRESSION; HIGH THROUGHPUT SEQUENCING; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HISTONE UBIQUITINATION; HUMAN; NONHUMAN; NUCLEOSOME; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PRIMORDIAL GERM CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; RNA ANALYSIS; RNA INTERFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE DIFFERENTIATION;

CARTILAGE, ARTICULAR; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HISTONES; HUMANS; MICRORNAS; OSTEOARTHRITIS;

EID: 84859433312     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2011.12.012     Document Type: Review

References (111)

1. Goldring S.R., Goldring M.B. Clinical aspects, pathology and pathophysiology of osteoarthritis. J Musculoskelet Neuronal Interact 2006 Oct-Dec, 6(4):376-378.
2. Goldring M.B. Molecular regulation of the chondrocyte phenotype. J Musculoskelet Neuronal Interact 2002 Dec, 2(6):517-520.
3. van den Berg W.B. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthritis Cartilage 2011 Apr, 19(4):338-341.
4. Murphy G., Nagase H. Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?. Nat Clin Pract 2008 Mar, 4(3):128-135.
5. Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev Mol Med 2005 May 24, 7(9):1-12.
6. Feng S., Jacobsen S.E., Reik W. Epigenetic reprogramming in plant and animal development. Science 2010 Oct 29, 330(6004):622-627.
7. Bird A. Perceptions of epigenetics. Nature 2007 May 24, 447(7143):396-398.
8. Fraga M.F., Esteller M. Epigenetics and aging: the targets and the marks. Trends Genet 2007 Aug, 23(8):413-418.
9. Skinner M.K., Manikkam M., Guerrero-Bosagna C. Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab 2010 Apr, 21(4):214-222.
10. Miranda T.B., Jones P.A. DNA methylation: the nuts and bolts of repression. J Cell Physiol 2007 Nov, 213(2):384-390.
11. Portela A., Esteller M. Epigenetic modifications and human disease. Nat Biotechnol 2010 Oct, 28(10):1057-1068.
12. Irizarry R.A., Ladd-Acosta C., Wen B., Wu Z., Montano C., Onyango P., et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009 Feb, 41(2):178-186.
13. Hellman A., Chess A. Gene body-specific methylation on the active X chromosome. Science 2007 Feb 23, 315(5815):1141-1143.
14. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992 Jun 12, 69(6):915-926.
15. Okano M., Bell D.W., Haber D.A., Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999 Oct 29, 99(3):247-257.
16. Goll M.G., Bestor T.H. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005, 74:481-514.
17. Sesselmann S., Soder S., Voigt R., Haag J., Grogan S.P., Aigner T. DNA methylation is not responsible for p21WAF1/CIP1 down-regulation in osteoarthritic chondrocytes. Osteoarthritis Cartilage 2009 Apr, 17(4):507-512.
18. Barcelo H.A., Wiemeyer J.C., Sagasta C.L., Macias M., Barreira J.C. Effect of S-adenosylmethionine on experimental osteoarthritis in rabbits. Am J Med 1987 Nov 20, 83(5A):55-59.
19. Kim J., Lee E.Y., Koh E.M., Cha H.S., Yoo B., Lee C.K., et al. Comparative clinical trial of S-adenosylmethionine versus nabumetone for the treatment of knee osteoarthritis: an 8-week, multicenter, randomized, double-blind, double-dummy, Phase IV study in Korean patients. Clin Ther 2009 Dec, 31(12):2860-2872.
20. Soeken K.L., Lee W.L., Bausell R.B., Agelli M., Berman B.M. Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis. J Fam Pract 2002 May, 51(5):425-430.
21. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., Carmouche R.P., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008 Mar 6, 452(7183):45-50.
22. Hajkova P., Jeffries S.J., Lee C., Miller N., Jackson S.P., Surani M.A. Genome-wide reprogramming in the mouse germ line entails the base excision repair pathway. Science 2010 Jul 2, 329(5987):78-82.
23. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009 May 15, 324(5929):929-930.
24. Guo J.U., Su Y., Zhong C., Ming G.L., Song H. Hydroxylation of 5-Methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011 Apr 29, 145(3):423-434.
25. Thomson J.P., Skene P.J., Selfridge J., Clouaire T., Guy J., Webb S., et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010 Apr 15, 464(7291):1082-1086.
26. Fernandez M.P., Young M.F., Sobel M.E. Methylation of type II and type I collagen genes in differentiated and dedifferentiated chondrocytes. J Biol Chem 1985 Feb 25, 260(4):2374-2378.
27. Poschl E., Fidler A., Schmidt B., Kallipolitou A., Schmid E., Aigner T. DNA methylation is not likely to be responsible for aggrecan down regulation in aged or osteoarthritic cartilage. Ann Rheum Dis 2005 Mar, 64(3):477-480.
28. Zimmermann P., Boeuf S., Dickhut A., Boehmer S., Olek S., Richter W. Correlation of COL10A1 induction during chondrogenesis of mesenchymal stem cells with demethylation of two CpG sites in the COL10A1 promoter. Arthritis Rheum 2008 Sep, 58(9):2743-2753.
29. Ezura Y., Sekiya I., Koga H., Muneta T., Noda M. Methylation status of CpG islands in the promoter regions of signature genes during chondrogenesis of human synovium-derived mesenchymal stem cells. Arthritis Rheum 2009 May, 60(5):1416-1426.
30. Chapman K., Takahashi A., Meulenbelt I., Watson C., Rodriguez-Lopez J., Egli R., et al. A meta-analysis of European and Asian cohorts reveals a global role of a functional SNP in the 5' UTR of GDF5 with osteoarthritis susceptibility. Hum Mol Genet 2008 May 15, 17(10):1497-1504.
31. Reynard L.N., Bui C., Canty-Laird E.G., Young D.A., Loughlin J. Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum Mol Genet 2011 Sep 1, 20(17):3450-3460.
32. Kevorkian L., Young D.A., Darrah C., Donell S.T., Shepstone L., Porter S., et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004 Jan, 50(1):131-141.
33. Roach H.I., Yamada N., Cheung K.S., Tilley S., Clarke N.M., Oreffo R.O., et al. Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. Arthritis Rheum 2005 Oct, 52(10):3110-3124.
34. Tate P.H., Bird A.P. Effects of DNA methylation on DNA-binding proteins and gene expression. Curr Opin Genet Dev 1993 Apr, 3(2):226-231.
35. Murayama A., Sakura K., Nakama M., Yasuzawa-Tanaka K., Fujita E., Tateishi Y., et al. A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory. Embo J 2006 Mar 8, 25(5):1081-1092.
36. Hashimoto K., Oreffo R.O., Gibson M.B., Goldring M.B., Roach H.I. DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes. Arthritis Rheum 2009 Nov, 60(11):3303-3313.
37. Iliopoulos D., Malizos K.N., Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007 Dec, 66(12):1616-1621.
38. Kouzarides T. Chromatin modifications and their function. Cell 2007 Feb 23, 128(4):693-705.
39. Jenuwein T., Allis C.D. Translating the histone code. Science 2001 Aug 10, 293(5532):1074-1080.
40. Clayton A.L., Hazzalin C.A., Mahadevan L.C. Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 2006 Aug 4, 23(3):289-296.
41. Gregoretti I.V., Lee Y.M., Goodson H.V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 2004 Apr 16, 338(1):17-31.
42. Inoue T., Hiratsuka M., Osaki M., Oshimura M. The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation. Cell Cycle 2007 May 2, 6(9):1011-1018.
43. Marchion D., Munster P. Development of histone deacetylase inhibitors for cancer treatment. Expert Rev Anticancer Ther 2007 Apr, 7(4):583-598.
44. Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009 Aug 14, 325(5942):834-840.
45. Lee D.Y., Teyssier C., Strahl B.D., Stallcup M.R. Role of protein methylation in regulation of transcription. Endocr Rev 2005 Apr, 26(2):147-170.
46. Trojer P., Reinberg D. Histone lysine demethylases and their impact on epigenetics. Cell 2006 Apr 21, 125(2):213-217.
47. Bonasio R., Tu S., Reinberg D. Molecular signals of epigenetic states. Science 2010 Oct 29, 330(6004):612-616.
48. Chabane N., Zayed N., Afif H., Mfuna-Endam L., Benderdour M., Boileau C., et al. Histone deacetylase inhibitors suppress interleukin-1beta-induced nitric oxide and prostaglandin E2 production in human chondrocytes. Osteoarthritis Cartilage 2008 Oct, 16(10):1267-1274.
49. Young D.A., Lakey R.L., Pennington C.J., Jones D., Kevorkian L., Edwards D.R., et al. Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 2005, 7(3):R503-R512.
50. Wang X., Song Y., Jacobi J.L., Tuan R.S. Inhibition of histone deacetylases antagonized FGF2 and IL-1beta effects on MMP expression in human articular chondrocytes. Growth Factors 2009 Feb, 27(1):40-49.
51. Burrage P.S., Huntington J.T., Sporn M.B., Brinckerhoff C.E. Regulation of matrix metalloproteinase gene expression by a retinoid X receptor-specific ligand. Arthritis Rheum 2007 Mar, 56(3):892-904.
52. Furumatsu T., Tsuda M., Yoshida K., Taniguchi N., Ito T., Hashimoto M., et al. Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J Biol Chem 2005 Oct 21, 280(42):35203-35208.
53. Hong S., Derfoul A., Pereira-Mouries L., Hall D.J. A novel domain in histone deacetylase 1 and 2 mediates repression of cartilage-specific genes in human chondrocytes. FASEB J 2009 Oct, 23(10):3539-3552.
54. Huh Y.H., Ryu J.H., Chun J.S. Regulation of type II collagen expression by histone deacetylase in articular chondrocytes. J Biol Chem 2007 Jun 8, 282(23):17123-17131.
55. Zayed N., El Mansouri F.E., Chabane N., Kapoor M., Martel-Pelletier J., Benderdour M., et al. Valproic acid suppresses interleukin-1ss-induced microsomal prostaglandin E2 synthase-1 expression in chondrocytes through upregulation of NAB1. J Rheumatol 2011 Mar, 38(3):492-502.
56. Chen W.P., Bao J.P., Hu P.F., Feng J., Wu L.D. Alleviation of osteoarthritis by trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. Mol Biol Rep 2010 Dec, 37(8):3967-3972.
57. Chung Y.L., Lee M.Y., Wang A.J., Yao L.F. A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis. Mol Ther 2003 Nov, 8(5):707-717.
58. Higashiyama R., Miyaki S., Yamashita S., Yoshitaka T., Lindman G., Ito Y., et al. Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis. Mod Rheumatol 2010 Feb, 20(1):11-17.
59. Huber L.C., Brock M., Hemmatazad H., Giger O.T., Moritz F., Trenkmann M., et al. Histone deacetylase/acetylase activity in total synovial tissue derived from rheumatoid arthritis and osteoarthritis patients. Arthritis Rheum 2007 Apr, 56(4):1087-1093.
60. El Mansouri F.E., Chabane N., Zayed N., Kapoor M., Benderdour M., Martel-Pelletier J., et al. Contribution of H3K4 methylation by SET-1A to interleukin-1-induced cyclooxygenase 2 and inducible nitric oxide synthase expression in human osteoarthritis chondrocytes. Arthritis Rheum 2011 Jan, 63(1):168-179.
61. Gagarina V., Gabay O., Dvir-Ginzberg M., Lee E.J., Brady J.K., Quon M.J., et al. SirT1 enhances survival of human osteoarthritic chondrocytes by repressing protein tyrosine phosphatase 1B and activating the insulin-like growth factor receptor pathway. Arthritis Rheum 2010 May, 62(5):1383-1392.
62. Dvir-Ginzberg M., Gagarina V., Lee E.J., Hall D.J. Regulation of cartilage-specific gene expression in human chondrocytes by SirT1 and nicotinamide phosphoribosyltransferase. J Biol Chem 2008 Dec 26, 283(52):36300-36310.
63. Fujita N., Matsushita T., Ishida K., Kubo S., Matsumoto T., Takayama K., et al. Potential involvement of SIRT1 in the pathogenesis of osteoarthritis through the modulation of chondrocyte gene expressions. J Orthop Res 2011 Apr, 29(4):511-515.
64. Takayama K., Ishida K., Matsushita T., Fujita N., Hayashi S., Sasaki K., et al. SIRT1 regulation of apoptosis of human chondrocytes. Arthritis Rheum 2009 Sep, 60(9):2731-2740.
65. Hong E.H., Lee S.J., Kim J.S., Lee K.H., Um H.D., Kim J.H., et al. Ionizing radiation induces cellular senescence of articular chondrocytes via negative regulation of SIRT1 by p38 kinase. J Biol Chem 2010 Jan 8, 285(2):1283-1295.
66. Dioum E.M., Chen R., Alexander M.S., Zhang Q., Hogg R.T., Gerard R.D., et al. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 2009 Jun 5, 324(5932):1289-1293.
67. Yang S., Kim J., Ryu J.H., Oh H., Chun C.H., Kim B.J., et al. Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 2010 Jun, 16(6):687-693.
68. Cohen-Kfir E., Artsi H., Levin A., Abramowitz E., Bajayo A., Gurt I., et al. Sirt1 is a regulator of bone mass and a repressor of sost encoding for sclerostin, a bone formation inhibitor. Endocrinology 2011 Dec, 152(12):4514-4524.
69. Vinciguerra M., Fulco M., Ladurner A., Sartorelli V., Rosenthal N. SirT1 in muscle physiology and disease: lessons from mouse models. Dis Model Mech 2010 May-Jun, 3(5-6):298-303.
70. Chang T.C., Mendell J.T. microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet 2007, 8:215-239.
71. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010 Aug 12, 466(7308):835-840.
72. Harfe B.D., McManus M.T., Mansfield J.H., Hornstein E., Tabin C.J. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci U S A 2005 Aug 2, 102(31):10898-10903.
73. Kobayashi T., Lu J., Cobb B.S., Rodda S.J., McMahon A.P., Schipani E., et al. Dicer-dependent pathways regulate chondrocyte proliferation and differentiation. Proc Natl Acad Sci U S A 2008 Feb 12, 105(6):1949-1954.
74. Wienholds E., Kloosterman W.P., Miska E., Alvarez-Saavedra E., Berezikov E., de Bruijn E., et al. microRNA expression in zebrafish embryonic development. Science 2005 Jul 8, 309(5732):310-311.
75. Tuddenham L., Wheeler G., Ntounia-Fousara S., Waters J., Hajihosseini M.K., Clark I., et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett 2006 Jul 24, 580(17):4214-4217.
76. Tardif G., Hum D., Pelletier J.P., Duval N., Martel-Pelletier J. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009, 10:148.
77. Miyaki S., Nakasa T., Otsuki S., Grogan S.P., Higashiyama R., Inoue A., et al. microRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 2009 Sep, 60(9):2723-2730.
78. Iliopoulos D., Malizos K.N., Oikonomou P., Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008, 3(11):e3740.
79. Vega R.B., Matsuda K., Oh J., Barbosa A.C., Yang X., Meadows E., et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 2004 Nov 12, 119(4):555-566.
80. Arnold M.A., Kim Y., Czubryt M.P., Phan D., McAnally J., Qi X., et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell 2007 Mar, 12(3):377-389.
81. Nicolas F.E., Pais H., Schwach F., Lindow M., Kauppinen S., Moulton V., et al. Experimental identification of microRNA-140 targets by silencing and overexpressing miR-140. RNA 2008 Dec, 14(12):2513-2520.
82. Pais H., Nicolas F.E., Soond S.M., Swingler T.E., Clark I.M., Chantry A., et al. Analyzing mRNA expression identifies Smad3 as a microRNA-140 target regulated only at protein level. RNA 2010 Mar, 16(3):489-494.
83. Miyaki S., Sato T., Inoue A., Otsuki S., Ito Y., Yokoyama S., et al. microRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010 Jun 1, 24(11):1173-1185.
84. Nakamura Y., Inloes J.B., Katagiri T., Kobayashi T. Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate BMP signaling. Mol Cell Biol 2011 May 16.
85. Zou W., Chen X., Shim J.H., Huang Z., Brady N., Hu D., et al. The E3 ubiquitin ligase Wwp2 regulates craniofacial development through mono-ubiquitylation of Goosecoid. Nat Cell Biol 2010 Jan, 13(1):59-65.
86. Eberhart J.K., He X., Swartz M.E., Yan Y.L., Song H., Boling T.C., et al. microRNA Mirn140 modulates Pdgf signaling during palatogenesis. Nat Genet 2008 Mar, 40(3):290-298.
87. Nakamura Y., Yamamoto K., He X., Otsuki B., Kim Y., Murao H., et al. Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25. Nat Commun 2011 Mar, 2:251.
88. He X., Yan Y.L., Delaurier A., Postlethwait J.H. Observation of miRNA gene expression in zebrafish embryos by in situ hybridization to microRNA primary transcripts. Zebrafish 2011 Mar, 8(1):1-8.
89. Jones S.W., Watkins G., Le Good N., Roberts S., Murphy C.L., Brockbank S.M., et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage 2009 Apr, 17(4):464-472.
90. Yamasaki K., Nakasa T., Miyaki S., Ishikawa M., Deie M., Adachi N., et al. Expression of microRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009 Apr, 60(4):1035-1041.
91. Lin L., Shen Q., Zhang C., Chen L., Yu C. Assessment of the profiling microRNA expression of differentiated and dedifferentiated human adult articular chondrocytes. J Orthop Res 2011 Apr 1.
92. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006 Aug 15, 103(33):12481-12486.
93. Li X., Gibson G., Kim J.S., Kroin J., Xu S., van Wijnen A.J., et al. microRNA-146a is linked to pain-related pathophysiology of osteoarthritis. Gene 2011 Jul 1, 480(1-2):34-41.
94. Akhtar N., Rasheed Z., Ramamurthy S., Anbazhagan A.N., Voss F.R., Haqqi T.M. microRNA-27b regulates the expression of matrix metalloproteinase 13 in human osteoarthritis chondrocytes. Arthritis Rheum 2010 May, 62(5):1361-1371.
95. Dudek K.A., Lafont J.E., Martinez-Sanchez A., Murphy C.L. Type II collagen expression is regulated by tissue-specific miR-675 in human articular chondrocytes. J Biol Chem 2010 Aug 6, 285(32):24381-24387.
96. Abouheif M.M., Nakasa T., Shibuya H., Niimoto T., Kongcharoensombat W., Ochi M. Silencing microRNA-34a inhibits chondrocyte apoptosis in a rat osteoarthritis model in vitro. Rheumatology (Oxford) 2010 Nov, 49(11):2054-2060.
97. Guan Y.J., Yang X., Wei L., Chen Q. MiR-365: a mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J 2011 Dec, 25(12):4457-4466.
98. Martinez-Sanchez A., Dudek K.A., Murphy C.L. Regulation of human chondrocyte function through direct inhibition of cartilage master-regulator SOX9 by miRNA-145. J Biol Chem 2011 Nov 18.
99. Yang B., Guo H., Zhang Y., Chen L., Ying D., Dong S. microRNA-145 regulates chondrogenic differentiation of mesenchymal stem cells by targeting Sox9. PLoS One 2011, 6(7):e21679.
100. Swingler T.E., Wheeler G., Carmont V., Elliott H.R., Barter M.J., Abu-Elmagd M., et al. The expression and function of microRNAs in chondrogenesis and osteoarthritis. Arthritis Rheum 2011 Dec 5.
101. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A 2011 Mar 22, 108(12):5003-5008.
102. Murata K., Yoshitomi H., Tanida S., Ishikawa M., Nishitani K., Ito H., et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 2010, 12(3):R86.
103. Laird P.W. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genet 2010 Feb 2, 11(3):191-203.
104. Schones D.E., Zhao K. Genome-wide approaches to studying chromatin modifications. Nat Rev Genet 2008 Mar, 9(3):179-191.
105. Linsen S.E., de Wit E., Janssens G., Heater S., Chapman L., Parkin R.K., et al. Limitations and possibilities of small RNA digital gene expression profiling. Nat Methods 2009 Jul, 6(7):474-476.
106. Thomas M., Lieberman J., Lal A. Desperately seeking microRNA targets. Nat Struct Mol Biol 2010 Oct, 17(10):1169-1174.
107. Cheung K.S., Hashimoto K., Yamada N., Roach H.I. Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation. Rheumatol Int 2009 Mar, 29(5):525-534.
108. de Andres M.C., Imagawa K., Hashimoto K., Gonzalez A., Goldring M.B., Roach H.I., et al. Suppressors of cytokine signalling (SOCS) are reduced in osteoarthritis. Biochem Biophys Res Commun 2011 Feb 23.
109. Loeser R.F., Im H.J., Richardson B., Lu Q., Chubinskaya S. Methylation of the OP-1 promoter: potential role in the age-related decline in OP-1 expression in cartilage. Osteoarthritis Cartilage 2009 Apr, 17(4):513-517.
110. Scott J.L., Gabrielides C., Davidson R.K., Swingler T.E., Clark I.M., Wallis G.A., et al. Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease. Ann Rheum Dis 2010 Aug, 69(8):1502-1510.
111. Ohgawara T., Kubota S., Kawaki H., Kondo S., Eguchi T., Kurio N., et al. Regulation of chondrocytic phenotype by micro RNA 18a: involvement of Ccn2/Ctgf as a major target gene. FEBS Lett 2009 Mar 18, 583(6):1006-1010.